fda compounding semaglutide crackdown news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compound versions of GLP-1 drugs

Brand Managed by Cre8tive Capital Holdings I Copyright 2026 RealFit Group International (Pty) Limited I All rights reserved

Medications like Ozempic are allowed through airport security, and medical supplies such as needles and cooling packs are typically permitted when properly packed and declared

Both medications have similar common side effects, namely gastrointestinal issues, including nausea, vomiting, pancreatitis, and diarrhea

Reducing Side Effects Nausea, bloating, vomiting, and loose stools are common side effects when taking the full dose of medication

Effects of Exogenous Glucagon-Like Peptide-1 on Gastric Emptying and Glucose Absorption in the Critically Ill: Relationship to Glycemia

When aqueous solutions freeze, ice crystals form